Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by gregoooon Jan 02, 2014 1:29pm
250 Views
Post# 22053261

IMO heres whats going to happen to SMQ

IMO heres whats going to happen to SMQ
 
Sereno Capital Corp
Symbol C : SZZ
Shares Issued 4,700,000
Recent Sedar Documents

They get our cash and we get a few DVO.U shares.

Sereno Capital combines with Delavaco Properties

2014-01-02 12:10 ET - News Release

 

Mr. Andrew DeFrancesco reports

DELAVACO RESIDENTIAL PROPERTIES CORP. ANNOUNCES COMPLETION OF QUALIFYING TRANSACTION

Delavaco Residential Properties Corp., formerly named Sereno Capital Corp., has completed its previously announced business combination with Delavaco Properties Inc. on the terms set out in the joint management information circular of Delavaco and Sereno dated Nov. 29, 2013. The transaction constituted the qualifying transaction of Sereno as defined under the policies of the TSX Venture Exchange.

It is currently anticipated that trading of the common shares of Delavaco will recommence on or about Jan. 3, 2014, under the symbol DVO.U. Delavaco shares will trade in United States dollars.

Andrew DeFrancesco, chairman and chief executive officer of Delavaco, comments: "We are very happy with the success Delavaco has achieved to date. As a public company, we will be able to accelerate our growth and therefore continue to be able to exploit the opportunities presenting themselves in the U.S. residential market. Thank you to GMP and PowerOne Capital Markets for their continued support."

Summary of the business combination

As part of the transaction, the common shares of DPI were cancelled and former shareholders of DPI received that number of Sereno common shares equal to (A) the number of DPI common shares so cancelled, multiplied by (B) 7.36.

At a special shareholders meeting of Sereno held on Dec. 30, 2013, Sereno shareholders approved the consolidation all of the issued and outstanding common shares of Sereno (including the consideration shares) on the basis of 7.36 preconsolidation shares for one postconsolidation Delavaco share. The common share purchase warrants of DPI and the incentive stock options of Sereno were also adjusted to become exercisable for Delavaco shares. Sereno shareholders also approved an amendment to the articles of incorporation to change Sereno's name to Delavaco Residential Properties Corp.

At a special shareholders meeting of DPI held on Dec. 30, 2013, DPI shareholders approved the completion of the business combination by way of a three-cornered amalgamation under the Business Corporation Act (Ontario) whereby DPI amalgamated with a wholly owned subsidiary of Sereno. Additional information on the transaction is included in the information circular and available on SEDAR.

To ensure that Delavaco met the minimum public board lot requirements of a Tier 2 real estate or investment issuer, a new special purpose entity (Sereno Finco) was established and completed an equity financing raising aggregate gross proceeds of $47,150 (U.S.), consisting of 41,000 special shares of Sereno Finco at $1.15 (U.S.) per share. The Sereno Finco shares were subsequently exchanged for an equivalent number of Delavaco shares such that the total number of issued and outstanding Delavaco shares on closing is 52,434,583, expressed on a non-diluted basis.

Reorganization

Prior to the completion of the transaction, DPI completed an internal reorganization, pursuant to which it indirectly acquired from Delavaco Real Estate Opportunities Corp. (DREOC), all of the issued and outstanding limited partnership units in certain limited partnerships holding title to various multifamily properties in Austin, Tex., and Sunrise, Fla. As consideration for the reorganization, DREOC received an aggregate of 14,149,844 Delavaco shares and subsequently distributed such shares to former securityholders of DREOC.

As disclosed more fully in the information circular, in addition to the reorganization, Delavaco had also contemplated acquiring the multifamily property held by Park Colony LLC, conditional upon the receipt of the consent of the Federal Home Loan Mortgage Corp. (Freddie Mac). The Freddie Mac consent was not obtained prior to the special shareholders meetings and in order to ensure that the transaction was consummated in a timely manner and to provide immediate liquidity and access to the capital markets, Delavaco decided to complete the transaction without acquiring the multifamily property held by Park Colony.

Board of directors and management

The board and management team now consists of the following individuals: Andrew DeFrancesco (chairman, chief executive officer and director), Michael Galloro (chief financial officer), Marc Muzzo (director), Keith L. Ray (director), Michael Serruya (director), Kelly Hanczyk (director) and Romeo De Gasperis (director).

Bullboard Posts